Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30
(-1.91%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddys inches up as USFDA completes audit at Formulations Srikakulum Plant Unit I
>>
USFDA completes audit at Dr. Reddy's Lab’s Formulations Srikakulam Plant
>>
Dr. Reddy’s surges on inking pact to acquire select business divisions of Wockhardt
>>
Dr. Reddy’s to acquire select business divisions of Wockhardt
>>
Dr. Reddy's arm, Curis amend collaboration pact for development, commercialization of CA-170
>>
Dr. Reddy’s Laboratories gains on launching Trientine Hydrochloride Capsules in US market
>>
Dr. Reddy’s Laboratories launches Trientine Hydrochloride Capsules in US market
>>
Dr. Reddys Laboratories informs about company updates
>>
Dr. Reddy's Laboratories informs about completion of auditing
>>
USFDA completes audit at Dr. Reddy's Lab’s Srikakulam plant
<<
<
59
60
61
...143
>
>>